Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts

Magnetic Resonance Materials in Physics, Biology and Medicine

Volumn 12, Issue 2-3, 2001, Pages 104-113

  Konda, Sheela D ^a,b,c   Aref, Michael ^a,b,d   Wang, Steven ^b,d   Brechbiel, Martin ^e   Wiener, Erik C ^a,b,c,d  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d University of Illinois at Urbana Champaign   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Dendrimer; Folate; Gadolinium; MRI; Ovarian cancer; Targeted contrast agents

Indexed keywords

FOLATE RECEPTOR; FOLIC ACID; GADOTERIDOL; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; BINDING AFFINITY; CONFERENCE PAPER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ERYTHROLEUKEMIA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; XENOGRAFT;

ANIMALS; CARRIER PROTEINS; CONTRAST MEDIA; FEMALE; FOLIC ACID; GADOLINIUM; HETEROCYCLIC COMPOUNDS; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; ORGANOMETALLIC COMPOUNDS; OVARIAN NEOPLASMS; RADIOLIGAND ASSAY; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0034981659     PISSN: 13528661     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1352-8661(01)00106-5     Document Type: Conference Paper

References (45)

1. Preoperative evaluation of patients with suspected ovarian cancer
2. Treated ovarian cancer: Comparison of MR imaging with serum CA-125 level and physical examination - A longitudinal study
3. Rationale and applications for macromolecular Gd-based contrast agents
4. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: Theory and design
5. Magnetic resonance imaging using gadolinium labeled monoclonal antibody
6. The demonstration of human tumors on nude mice using gadolinium-labeled monoclonal antibodies for magnetic resonance imaging
7. Ferromagnetic particles as contrast agents for magnetic resonance imaging of the liver and spleen
8. Ferromagnetic contrast agents: A new approach
9. Monoclonal antibody-coated magnetite particles as contrast agents in magnetic resonance imaging of tumors
10. Polyclonal human immunoglobulin G labeled with polymeric iron oxide: Antibody MR imaging
11. Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging
12. Pancreatic receptors: Initial feasibility studies with a targeted contrast agent for MR imaging
13. Receptor imaging: Application to MR imaging of liver cancer
14. Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways
15. 3-targeted magnetic resonance imaging
16. ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging
17. Dendrimer-based metal chelates: A new class of magnetic resonance imaging contrast agents
18. Using starburst dendrimers as linker molecules to radiolabel antibodies
19. Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors
20. Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor
21. The development of a tumor targeting magnetic resonance contrast agent using the high affinity folate receptor: Work in progress
22. Immunologic and pharmacologic concepts of monoclonal antibodies
23. Delivery of macromolecules into living cells: A method that exploits folate receptor endocytosis
24. Cytotoxicity of mormordin-folate conjugates in cultured human cells
25. Cytotoxicity of folate-pseudomonas exotoxin conjugates toward tumor cells
26. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines
27. Cellular localization of the folate receptor: Potential role in drug toxicity and folate homeostasis
28. Folate-binding protein is a marker for ovarian cancer
29. Characterization of human ovarian carcinoma-associated antigens by novel monoclonal antibodies with tumor-restricted specificity
30. Immunohistochemical reactivity of a monoclonal antibody prepared against human ovarian carcinoma on normal and pathological female genital tissues
31. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein
32. Cellular localization of the folate receptor: Potential role in drug toxicity and folate homeostasis
33. Trophoblast and ovarian cancer antigen LK26
34. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues
35. The folate receptor in central nervous system malignancies of childhood
36. Immobilization system for rat brain imaging
37. Transport of molecules in the tumor interstitium: A review
38. Endocytosis of GPI-linked membrane folate-receptor-[alpha]
39. A human membrane-associated folate binding protein is anchored by a glycosyl-phospatidylinositol tail
40. The interrelationship of the soluble and membrane-associated folate-binding proteins in human KB cells
41. The biological chemistry of folate receptors
42. Over expression of folate binding protein in ovarian cancers
43. Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer
44. Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells
45. Can receptors be imaged with MRI agents